Loading…
Revvity, Inc. is projected to rise to $142.14 by 2027, a +27% move from its current price of $112.29. RVTY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $110.01 | $112.36 | $114.76 | +0.06% |
| Jul 14 | $109.12 | $112.43 | $115.84 | +0.13% |
| Jul 15 | $108.46 | $112.50 | $116.70 | +0.19% |
| Jul 16 | $107.91 | $112.57 | $117.43 | +0.25% |
| Jul 17 | $107.44 | $112.64 | $118.09 | +0.31% |
| Jul 18 | $107.03 | $112.71 | $118.70 | +0.38% |
| Jul 19 | $106.65 | $112.78 | $119.27 | +0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $106.65 | $112.78 | $119.27 | +0.44% |
| Week 2 | $104.67 | $113.28 | $122.60 | +0.88% |
| Week 3 | $103.28 | $113.78 | $125.35 | +1.33% |
| Week 4 | $102.19 | $114.28 | $127.81 | +1.77% |
| Week 5 | $101.29 | $114.78 | $130.07 | +2.22% |
| Week 6 | $100.53 | $115.29 | $132.22 | +2.67% |
| Week 7 | $99.87 | $115.80 | $134.26 | +3.12% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services.
It offers instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.
The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc.
in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Revvity, Inc. (RVTY) is a healthcare stock with a current price of $113.53 and a market capitalization of $12.67B. It is ranked 795 by market cap.
The price outlook is bullish over the longer horizon, with the forecast showing a rising path of average prices across years. The 2026 forecast carries an average of $113.53, with higher projections in subsequent years, edging toward substantial gains by 2030 and beyond.
A major floor 26.7% below — a decisive break under it would weaken the trend.
The nearest floor, 12.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.3% away) — a breakout level to watch.
A major ceiling 10.3% above — clearing it would confirm fresh momentum.
Key RVTY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RVTY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $111.92 | Buy | $111.96 | Buy |
| MA 10 | $112.17 | Buy | $110.91 | Buy |
| MA 20 | $107.03 | Buy | $108.16 | Buy |
| MA 50 | $100.88 | Buy | $102.77 | Buy |
| MA 100 | $95.97 | Buy | $99.57 | Buy |
| MA 200 | $97.26 | Buy | $98.38 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.41 | Neutral |
| Stoch RSI (14) | 54.81 | Neutral |
| CCI (20) | 60.59 | Neutral |
| Williams %R (14) | -9.99 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 12.40 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 90.01 | Sell |
| TRIX (15) | 0.50 | Buy |
| Awesome (5,34) | 7.78 | Buy |
| Ultimate (7,14,28) | 59.66 | Neutral |
| Momentum (10) | -1.24 | Sell |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 111.39 | Buy |
| ADX (14) | 21.98 | Buy |
| ATR (14) | 1.95 | Info |
The 30-day technical picture is bullish, with RSI14 at 70 indicating upside momentum. The near-term trend is supported by the SMA50 at $96.52 and the SMA200 at $95.91, placing the price above both moving averages.
Key near-term levels are a support at $93.97 and a resistance at $113.53. The 30-day price range spans from $95.66 to $134.74, highlighting potential near-term volatility within a constructive landscape.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $82.26 | $112.29 | $156.63 | 0% | Neutral | |
| $115.54 | $142.14 | $183.47 | +27% | Bullish | |
| $138.34 | $173.82 | $231.09 | +55% | Bullish | |
| $167.84 | $214.59 | $292.01 | +91% | Bullish | |
| $176.87 | $229.60 | $318.65 | +104% | Bullish | |
| $193.75 | $255.02 | $360.09 | +127% | Bullish | |
| $206.37 | $275.13 | $394.57 | +145% | Bullish | |
| $210.35 | $283.81 | $412.80 | +153% | Bullish | |
| $249.12 | $339.95 | $500.93 | +203% | Bullish | |
| $288.44 | $397.88 | $593.46 | +254% | Bullish | |
| $379.13 | $548.91 | $861.70 | +389% | Bullish | |
| $832.16 | $1,306.69 | $2,212.13 | +10.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $82.26 | $112.29 | $134.50 | +0.00% |
| August 2026 | $100.29 | $117.65 | $141.20 | +4.77% |
| September 2026 | $100.81 | $118.91 | $143.95 | +1.07% |
| October 2026 | $100.48 | $119.06 | $145.20 | +0.13% |
| November 2026 | $103.48 | $123.10 | $151.05 | +3.39% |
| December 2026 | $106.31 | $126.92 | $156.63 | +3.11% |
Click any year to see its month-by-month RVTY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect RVTY to range from $82.26 to $156.63 through 2026. The $112.29 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The RVTY price prediction for 2027 points to an average of $142.14 (low $115.54, high $183.47) — a potential gain of +27% on today's $112.29. Buyers look set to stay in control over this stretch.
In 2028, RVTY is projected to trade between $138.34 and $231.09, averaging $173.82 — a potential gain of +55% from today's $112.29. That is up +22% on the projected 2027 average. Momentum favours further upside here.
Revvity, Inc.'s 2029 outlook centres on $214.59, within a $167.84 to $292.01 range. That is up +23% on the projected 2028 average. That marks a +91% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, RVTY could reach as high as $318.65, with a base case around $229.60 and support toward $176.87 — roughly +104% from $112.29. Momentum favours further upside here.
Expect RVTY to range from $193.75 to $360.09 through 2031. The $255.02 average target implies a +127% move from current prices. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The RVTY price prediction for 2032 points to an average of $275.13 (low $206.37, high $394.57) — a potential gain of +145% on today's $112.29. Momentum favours further upside here.
In 2033, RVTY is projected to trade between $210.35 and $412.80, averaging $283.81 — a potential gain of +153% from today's $112.29. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Revvity, Inc.'s 2034 outlook centres on $339.95, within a $249.12 to $500.93 range. That is up +20% on the projected 2033 average. That marks a +203% change versus current levels. Momentum favours further upside here.
By 2035, RVTY could reach as high as $593.46, with a base case around $397.88 and support toward $288.44 — roughly +254% from $112.29. Buyers look set to stay in control over this stretch.
Expect RVTY to range from $379.13 to $861.70 through 2040. The $548.91 average target implies a +389% move from current prices. That is up +38% on the projected 2035 average. Momentum favours further upside here.
The RVTY price prediction for 2050 points to an average of $1,306.69 (low $832.16, high $2,212.13) — a potential gain of +10.6x on today's $112.29. Buyers look set to stay in control over this stretch.
Investing $1,000 in RVTY today (≈ 8.905513 RVTY) could be worth
$11,636.78
+$10,636.78 (+1064%) by 2050 · US Dollar
Based on the average projected RVTY price of $1,306.69 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RVTYwould be worth at today's price.
$1,000 invested in RVTY on Jul 10, 2025 (≈ 9.765625 RVTY) would be worth
$1,096.58
+$96.58 (+9.7%) today · 1.10× · US Dollar
Based on a RVTY entry price of $102.4 vs. today's $112.29.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $113.76 | $987.08 | -1.3% |
| 1 month ago | $101.29 | $1,108.6 | +10.9% |
| 3 months ago | $89.79 | $1,250.58 | +25.1% |
| 6 months ago | $103.89 | $1,080.85 | +8.1% |
| 1 year ago | $102.4 | $1,096.58 | +9.7% |
| All time (5.0y) ago | $153.15 | $733.2 | -26.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RVTY forecast.
Our base-case forecast reaches $220.00 around 2030.
Implied market cap at $220.00: $24.54B
The multi-year forecast shows a bullish trajectory, with 2027 averaging $144.35 and a 27.1% ROI, continuing a steady climb in following years. The 2028 forecast sits at an average of $181.50 with a 59.9% ROI, and 2029 at $223.49 with a 96.9% ROI.
By 2030, the average forecast reaches $236.81 with an 108.6% ROI, and 2040 shows $566.07 on average with a 398.6% ROI. The long view extends to 2050, with an average of $1,348.79 and a 1088% ROI, and a max forecast of $2,449.16, indicating substantial upside despite inherent uncertainty.
Tap a question to reveal the answer.
In 2030 the forecasted average price is $236.81, with a min of $176.86 and a max of $341.35. The ROI is 108.6% and sentiment is BULLISH.
Forecasts show a bullish sentiment from 2027 onward, with rising averages (e.g., $144.35 in 2027, $181.50 in 2028, $236.81 in 2030) and ROIs of 27.1%, 59.9%, 108.6% respectively, continuing through 2040 (398.6% ROI) and 2050 (1088% ROI). These are estimates, not guarantees.
Yes. The max forecast for 2050 is $2,449.16, which exceeds $2,000.
Current price is $113.53. The 30-day range runs from $95.66 to $134.74.
RSI14 is 70, indicating bullish momentum. The 50-day and 200-day moving averages are $96.52 and $95.91 respectively, with a support at $93.97 and resistance at $113.53.
Revvity, Inc. Community Discussion
0Share your Revvity, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.